GlassScriptPhysician profile
Vikas Prasad
NPI 1811600430
$15,283.68
in general payments reported to CMS, 2019-2025
5 companies · $6,745 in 2025
The $6,745 reported for 2025 was more than what 94% of Nuclear Medicine providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $897 · 2024: $7,642 · 2025: $6,745.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,600 · Honoraria: $3,250 · Travel and Lodging: $2,595 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,545 · Food and Beverage: $289 · Education: $4.29.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,600.00 |
| Honoraria | $3,250.00 |
| Travel and Lodging | $2,595.27 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,545.00 |
| Food and Beverage | $289.12 |
| Education | $4.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Curium US LLC | $10,298.59 | 2024-2025 | Detectnet |
| Telix Pharmaceuticals | $1,986.53 | 2023-2024 | Illuccix |
| Siemens Medical Solutions USA, INC. | $1,545.00 | 2025 | Biograph Vision 600 (8 Ring/64 Ct) |
| Eli Lilly and Company | $1,453.56 | 2024 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vikas Prasad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.